Effectiveness of MI Paste Plus and Remin Pro on Remineralization of Post-Orthodontic White Spot Lesions
Evaluation of the Efficiency of Different Remineralization Methods Used In the Treatment of Post-Orthodontic White Spot Lesions With Quantitative Light-Induced Fluorescence Method
1 other identifier
interventional
39
1 country
1
Brief Summary
One of the most undesired side effects of fixed orthodontic treatment is white spot lesions (WSLs), that appear on the buccal surface of teeth and cause aesthetic problems. The aim of this prospective study was to quantitively evaluate the remineralization effect of casein phosphopeptide-amorphous calcium fluorophosphate (CPP-ACFP) containing (MI Paste Plus®) and hydroxyapatite, xylitol and fluoride containing (Remin Pro®) agents in remineralizing post orthodontics white spots using Quantitive Light-Induced Fluorescence Method (QLF) and ICDAS II criteria, compared to a control group in whom just a routine home care was instructed. Thirty-nine individuals who had recently completed orthodontic treatment, had at least one WSL on upper anterior teeth and aged between 12-25 years were included. The participants were randomly assigned into three groups of 13 each; (1) MI Paste Plus + routine home care; (2) Remin Pro + routine home care; and (3) routine home care (control). The treatment/ observation period was 12 weeks after bracket debonding. Fluorescence loss (∆F, %), lesion area (LA, mm2), lesion volume (∆Q, % × mm2), maximum fluorescence loss (∆Fmax), ICDAS II criteria of WSLs were measured at beginning (T0) and 4 (T1), 8 (T2), and 12 (T3) weeks later. Statistical significance was set at p\<0.05.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 25, 2022
CompletedFirst Submitted
Initial submission to the registry
September 18, 2023
CompletedFirst Posted
Study publicly available on registry
December 20, 2023
CompletedDecember 20, 2023
December 1, 2023
2 years
September 18, 2023
December 11, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Mineral Content Assessment (ΔF / Depth of lesion)
The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
Mineral Content Assessment (LA / Lesion area)
The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
Mineral Content Assessment (∆Q / Lesion volume)
The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
Mineral Content Assessment (∆Fmax / Maximum fluorescence loss)
The buccal surfaces of the teeth were examined and evaluated by light induced fluorescence intraoral camera QLF-D Biluminator,™ (Inspektor-Pro, Amsterdam, Holland) for capturing fluorescent photographs in accordance with the manufacturer's instructions.
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
Secondary Outcomes (1)
Visual Caries Regression Assessment
The patients were evaluated at baseline (T0) and every 30 days intervals for 3 months.
Study Arms (3)
MI Paste Plus
EXPERIMENTALPatients were instructed to use MI Paste Plus (GC Europe, Leuven, Belgium) according to manufacturers instructions.
Remin Pro
EXPERIMENTALPatients were instructed to use (Remin Pro, VOCO GmbH, Cuxhaven, Germany) a pea-sized amount of the cream.
Control
ACTIVE COMPARATORPatients used a 1450 ppm fluoridated tooth paste (Colgate Sensitive Pro-Relief, Colgate-Palmolive, Swidnica, Poland) for conventional tooth brushing.
Interventions
Briefly, a pea-sized amount of the cream was used once a day and was allowed to remain on the teeth for three minutes after conventional tooth brushing. Patient was advised to not to spit out the cream for 30 seconds to activate the product with saliva. Patient was advised to spit out the remaining amount to avoid swallowing excessive fluoride and to wait for 30 minutes after the treatment before rinsing or eating or drinking.
The cream must remain on the teeth for at least three minutes once daily after conventional tooth brushing. Patient was advised to spit out the remaining amount to avoid swallowing excessive fluoride and to wait for 30 minutes after the treatment before rinsing or eating or drinking.
Eligibility Criteria
You may qualify if:
- to 25 years of age,
- at least 12 months of orthodontic treatment with braces,
- at least one upper anterior tooth with WSL.
You may not qualify if:
- smoking,
- enamel hypoplasia or fluorosis,
- active periodontal disease,
- dentin caries,
- allergy to casein,
- previous bleaching.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sevgi Göl Peynirci
Konak, İzmir, 35220, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Blinding was not feasible during the intervention, but the data evaluation and outcome assessment were blinded.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
September 18, 2023
First Posted
December 20, 2023
Study Start
February 1, 2020
Primary Completion
February 1, 2022
Study Completion
May 25, 2022
Last Updated
December 20, 2023
Record last verified: 2023-12